- Advertisement -
Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the US market.
Currently all COVID-19 treatments used in the…

